Myocardial scar rate from myocarditis on Cardiac Magnetic Resonance Imaging: Multisystem Inflammatory Syndrome (MIS-C) and COVID-19 vaccine-associated pattern in pediatric patients.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20240405001

Enrollment

Registered

2024-04-05

Start date

2023-11-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with myocarditis either from covid19 vaccine or MISC. Multisystem inflammatory syndrome in children covid vaccine myocarditis cardiac MRI

Interventions

Pediatric patients with history of COVID-19 infection from positive RT-PCR within 4-6 weeks who had fever of at least 38 degree celsius more than 24 hrs and had more than 2 system involvements includi

Prevention,Prevention

MIS-C assiciated myocarditis,Vaccine-associated myocarditis

Eligibility

Sex/Gender

All

Age

1 Days to 18 Years

Inclusion criteria

Inclusion criteria: All patients aged younger than 18 years old who diagnosed as Vaccine-associated myocarditis or myocarditis due to MIS-C induced.

Exclusion criteria

Exclusion criteria: Patients with underlying structural heart disease

Design outcomes

Primary

Measure	Time frame
MISC Myocardial fibrosis at 4-6 weeks after onset of symptoms Rate of LGE on MRI,VAM Myocardial fibrosis at 2weeks after vaccination Rate of LGE on MRI	—

Secondary

Measure	Time frame
Myocardial dysfuntion within 8 weeks after MRI LVEF on echocardiogram	—

Countries

Thailand

Contacts

Public ContactSuvicha Khampunnip

Phramongkutklao hospital

canjang@hotmail.com0879978324

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026